Statistical methods for assessment of added usefulness of new biomarkers

Relations of Biomarkers of Distinct Pathophysiological Pathways and Atrial Fibrillation Incidence in the Community

(2010) Renate B. Schnabel et al.   CIRCULATION

Predicting the 30-Year Risk of Cardiovascular Disease

(2009) Michael J. Pencina et al.   CIRCULATION

Criteria for Evaluation of Novel Markers of Cardiovascular Risk

(2009) Mark A. Hlatky et al.   CIRCULATION

Assessment of Claims of Improved Prediction Beyond the Framingham Risk Score

(2009) Ioanna Tzoulaki   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study

(2009) Renate B Schnabel et al.   LANCET

C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction

(2008) Paul M Ridker et al.   CIRCULATION

General Cardiovascular Risk Profile for Use in Primary Care

(2008) Ralph B. D’Agostino et al.   CIRCULATION

C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart Study

(2008) Peter W.F. Wilson et al.  

Genotype Score in Addition to Common Risk Factors for Prediction of Type 2 Diabetes

(2008) James B. Meigs et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE